Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., Ltd (HKPD) Revenue
Annual & quarterly revenue history · segment & region breakdown
HKPD · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsCellyan Biotechnology Co., Ltd trailing twelve-month (TTM) revenue is $0.04B, an increase of 21.72% year-over-year from $0.02B in FY2025.
Revenue trend
2025 – 2023 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-03-31 | $0.02B | +$0.00B | +21.72% |
| 2024-03-31 | $0.02B | +$0.00B | +32.91% |
| 2023-03-31 | $0.01B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Cellyan Biotechnology Co., Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Cellyan Biotechnology Co., Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Cellyan Biotechnology Co., Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HKPD revenue · 4 questionsHKPD's trailing twelve-month (TTM) revenue is $0.04B. That is an increase of 21.72% year-over-year from $0.02B in FY2025.
▸ Source: FMP · Cellyan Biotechnology Co., Ltd SEC filings · GAAP · Cellyan Biotechnology Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026